← Open Payments lookup

KIMBERLY WOODLIFF: Open Payments

NPI 1699309393 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,184 in 73 payments from 12 companies in 2025. Trend: 2023 $839 · 2024 $1,317 · 2025 $3,184

Food & beverage: $2,054Consulting: $732Education: $398
CompanyPaymentsAmount
GENZYME CORPORATION21$1,857
GlaxoSmithKline, LLC.22$443
Actelion Pharmaceuticals US, Inc.7$325
Regeneron Healthcare Solutions, Inc.8$269
SANOFI-AVENTIS U.S. LLC1$100
AstraZeneca Pharmaceuticals LP3$49
Phathom Pharmaceuticals, Inc.5$46
Electromed, Inc.2$28
United Therapeutics Corporation1$21
Verona Pharma, Inc.1$16

Products named: DUPIXENT, NUCALA, OPSUMIT, TRELEGY ELLIPTA, UPTRAVI, VOQUEZNA, BREZTRI, SMARTVEST.

Industry payments across TX — which companies pay providers there.